Drug Trial Radar · NCT06162221
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Last checked: Nov 20, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
616
Planned (sponsor's estimate)
Start
Jan 18, 2024
Primary completion
Jun 2027
Study completion Dec 2028
Sponsor
- Lead sponsor
- Revolution Medicines, Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 8, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON) inhibitors as a monotherapy or combined with Standard(s) of Care (SOC) or with each other. The first four subprotocols include the following: Subprotocol A: RMC-6291 +/- RMC-6236 + SOC Subprotocol B: RMC-6236 + SOC Subprotocol C: RMC-9805 +/- RMC-6236 + SOC Subprotocol D: RMC-9805
Conditions
- Non-Small Cell Lung Cancer, NSCLC
- KRAS, NRAS, HRAS-mutated NSCLC
- KRAS G12C-mutated Solid Tumors, Lung Cancer
- Lung Cancer Stage IV, Advanced Solid Tumor, Cancer
- RAS G12D-mutated NSCLC
Interventions
RMC-6291Drug
Oral tablet
RMC-6236Drug
Oral tablet
PembrolizumabDrug
IV Infusion
CisplatinDrug
IV Infusion
CarboplatinDrug
IV Infusion
PemetrexedDrug
IV infusion
RMC-9805Drug
Oral Tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse eventsTime frame: Up to 5 years
- Dose limiting toxicitiesTime frame: 21 days
Locations
98 sites in 13 countries. Site status is shown where the registry gives one.
Banner MD Anderson Cancer Center
Gilbert, Arizona · Recruiting
City of Hope - Duarte
Duarte, California · Active not recruiting
City of Hope - Lennar
Irvine, California · Active not recruiting
University of California Los Angeles
Los Angeles, California · Active not recruiting
UC Davis, Davis Comprehensive Cancer Center
Sacramento, California · Recruiting
University of California, San Diego Moores Cancer Center
San Diego, California · Recruiting
UCSF Medical Center - Mission Bay
San Francisco, California · Recruiting
Stanford University - Stanford Cancer Institute
Stanford, California · Recruiting
Kaiser Permanente
Vallejo, California · Active not recruiting
Georgetown University Medical Center
Washington D.C., District of Columbia · Recruiting
Boca Raton Clinical Research Associates
Plantation, Florida · Recruiting
Cancer Specialists of North Florida
Saint Augustine, Florida · Active not recruiting
H Lee Moffitt Cancer Center and Research Institute
Tampa, Florida · Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts · Recruiting
Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion)
Detroit, Michigan · Active not recruiting
Intermountain Health - St. Vincent Frontier Cancer Center
Billings, Montana · Active not recruiting
Nebraska Cancer Specialist
Grand Island, Nebraska · Recruiting
New York University Langone Health
New York, New York · Recruiting
Icahn School of Medicine at Mount Sinai
New York, New York · Active not recruiting
Columbia University Medical Center
New York, New York · Recruiting
Clinical Research Alliance
Westbury, New York · Active not recruiting
University Hospitals Cleveland Medical Center
Cleveland, Ohio · Recruiting
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania · Recruiting
Baptist Medical Center
Memphis, Tennessee · Recruiting
Tennessee Oncology
Nashville, Tennessee · Recruiting
The University of Texas MD Anderson Cancer Center
Houston, Texas · Recruiting
NEXT Oncology Dallas
Irving, Texas · Recruiting
NEXT Oncology Virginia
Fairfax, Virginia · Recruiting
Fred Hutchinson Cancer Research Center
Seattle, Washington · Active not recruiting
Chris O'Brien Lifehouse Hosptial
Camperdown, New South Wales, Australia · Active not recruiting
Liverpool Hospital
Liverpool, New South Wales, Australia · Active not recruiting
Royal North Shore Hospital
St Leonards, New South Wales, Australia · Active not recruiting
Monash Health
Clayton, Victoria, Australia · Active not recruiting
Linear Clinical Research
Nedlands, Western Australia, Australia · Active not recruiting
Wiener Gesundheitsverbund - Klinik Floridsdorf
Vienna, Austria · Active not recruiting
Universitätsklinikum St. Pölten
Sankt Pölten, Austria, Austria · Active not recruiting
Nemocnice AGEL Novy Jicin a.s
Nový Jičín, Czech Republic, Czechia · Active not recruiting
Rigshospitalet
Copenhagen, Denmark · Recruiting
Odense University Hospital, Department of Oncology
Odense, Denmark · Recruiting
Institut de Cancerologie de Ouest (ICO) - Angers
Angers, France · Recruiting
Showing 40 of 98 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.